| Literature DB >> 34127656 |
Chao Ma1,2,3, Jing Sun3,4, Bo Li4, Yang Feng4, Yao Sun4, Li Xiang5, Baiheng Wu6, Lingling Xiao4, Baimei Liu4, Vladislav S Petrovskii7,8, Jinrui Zhang4, Zili Wang4, Hongyan Li2,9, Lei Zhang4, Jingjing Li4, Fan Wang4, Robert Gӧstl9, Igor I Potemkin7,9,10, Dong Chen6, Hongbo Zeng5, Hongjie Zhang1,4, Kai Liu11,12, Andreas Herrmann13,14,15.
Abstract
The development of biomedical glues is an important, yet challenging task as seemingly mutually exclusive properties need to be combined in one material, i.e. strong adhesion and adaption to remodeling processes in healing tissue. Here, we report a biocompatible and biodegradable protein-based adhesive with high adhesion strengths. The maximum strength reaches 16.5 ± 2.2 MPa on hard substrates, which is comparable to that of commercial cyanoacrylate superglue and higher than other protein-based adhesives by at least one order of magnitude. Moreover, the strong adhesion on soft tissues qualifies the adhesive as biomedical glue outperforming some commercial products. Robust mechanical properties are realized without covalent bond formation during the adhesion process. A complex consisting of cationic supercharged polypeptides and anionic aromatic surfactants with lysine to surfactant molar ratio of 1:0.9 is driven by multiple supramolecular interactions enabling such strong adhesion. We demonstrate the glue's robust performance in vitro and in vivo for cosmetic and hemostasis applications and accelerated wound healing by comparison to surgical wound closures.Entities:
Year: 2021 PMID: 34127656 DOI: 10.1038/s41467-021-23117-9
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919